Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects

NCT00434577 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

715

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: Herpes Zoster vaccine GSK1437173A Low Dose
BIOLOGICAL: Herpes Zoster vaccine GSK1437173A Medium Dose
BIOLOGICAL: Herpes Zoster vaccine GSK1437173A High Dose
BIOLOGICAL: Herpes Zoster vaccine GSK1437173A Modified
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline